{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:05:53Z","timestamp":1790741153369,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s40264-015-0353-1","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T22:42:13Z","timestamp":1444257733000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project"],"prefix":"10.1007","volume":"39","author":[{"given":"Emanuel","family":"Raschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Poluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariola","family":"Koci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Suling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Antoniazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Perina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Hazell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Ponti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"353_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","volume":"36","author":"N Stockbridge","year":"2013","unstructured":"Stockbridge N, Morganroth J, Shah RR, Garnett C. Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated? Drug Saf. 2013;36:167\u201382.","journal-title":"Drug Saf."},{"key":"353_CR2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/pds.1607","volume":"17","author":"C Astr\u00f6m-Lilja","year":"2008","unstructured":"Astr\u00f6m-Lilja C, Odeberg JM, Ekman E, Hagg S. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2008;17:587\u201392.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"353_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1517\/14740338.6.6.713","volume":"6","author":"IW Hammond","year":"2007","unstructured":"Hammond IW, Gibbs TG, Seifert HA, Rich DS. Database size and power to detect safety signals in pharmacovigilance. Expert Opin Drug Saf. 2007;6:713\u201321.","journal-title":"Expert Opin Drug Saf."},{"key":"353_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2515\/therapie\/2013016","volume":"68","author":"Y Arimone","year":"2013","unstructured":"Arimone Y, Bidault I, Dutertre JP, Gerardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Th\u00e9ophile H, Valnet-Rabier MB, Cercle de R\u00e9flexion sur l\u2019Imputabilit\u00e9 (CRI). Updating the French method for the causality assessment of adverse drug reactions. Therapie. 2013;68:69\u201376.","journal-title":"Therapie."},{"key":"353_CR5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00228-014-1657-2","volume":"70","author":"F Salvo","year":"2014","unstructured":"Salvo F, Raschi E, Moretti U, Chiarolanza A, Fourrier-Reglat A, Moore N, Sturkemboom M, De Ponti F, Poluzzi E, Pariente A. Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation. Eur J Clin Pharmacol. 2014;70:617\u201325.","journal-title":"Eur J Clin Pharmacol."},{"key":"353_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40264-013-0032-z","volume":"36","author":"E Poluzzi","year":"2013","unstructured":"Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER, Sturkenboom M, De Ponti F. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf. 2013;36:467\u201379.","journal-title":"Drug Saf."},{"key":"353_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/9781118820186.ch20","volume-title":"Mann\u2019s Pharmacovigilance","author":"A Bate","year":"2014","unstructured":"Bate A, Pariente A, Hauben M, B\u00e9gaud B. Quantitative signal detection and analysis in pharmacovigilance. In: Andrews E, Moore N, editors. Mann\u2019s Pharmacovigilance. London: Wiley; 2014. p. 331\u201354."},{"key":"353_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11531850-000000000-00000","volume":"33","author":"E Poluzzi","year":"2010","unstructured":"Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System. Drug Saf. 2010;33:303\u201314.","journal-title":"Drug Saf."},{"key":"353_CR9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1540-8159.1998.tb00148.x","volume":"21","author":"DM Roden","year":"1998","unstructured":"Roden DM. Taking the \u201cidio\u201d out of \u201cidiosyncratic\u201d: predicting torsades de pointes. Pacing Clin Electrophysiol. 1998;21:1029\u201334.","journal-title":"Pacing Clin Electrophysiol."},{"key":"353_CR10","first-page":"104","volume":"1","author":"E Raschi","year":"2013","unstructured":"Raschi E, Poluzzi E, Koci A, Moretti U, Sturkenboom M, De Ponti F. Macrolides and torsadogenic risk: emerging issues from the FDA pharmacovigilance database. J Pharmacovigilance. 2013;1:104.","journal-title":"J Pharmacovigilance."},{"key":"353_CR11","doi-asserted-by":"crossref","first-page":"e81208","DOI":"10.1371\/journal.pone.0081208","volume":"8","author":"E Raschi","year":"2013","unstructured":"Raschi E, Poluzzi E, Godman B, Koci A, Moretti U, Kalaba M, Bennie M, Barbui C, Wettermark B, Sturkenboom M, De Ponti F. Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One. 2013;8:e81208.","journal-title":"PLoS One."},{"key":"353_CR12","doi-asserted-by":"crossref","first-page":"e0119551","DOI":"10.1371\/journal.pone.0119551","volume":"10","author":"E Poluzzi","year":"2015","unstructured":"Poluzzi E, Raschi E, Godman B, Koci A, Moretti U, Kalaba M, Wettermark B, Sturkenboom M, De Ponti F. Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe. PLoS One. 2015;10:e0119551.","journal-title":"PLoS One."},{"key":"353_CR13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2165\/11584390-000000000-00000","volume":"33","author":"HW Wang","year":"2010","unstructured":"Wang HW, Hochberg AM, Pearson RK, Hauben M. An experimental investigation of masking in the US FDA adverse event reporting system database. Drug Saf. 2010;33:1117\u201333.","journal-title":"Drug Saf."},{"key":"353_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427\u201336.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"353_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/11597180-000000000-00000","volume":"35","author":"I Ahmed","year":"2012","unstructured":"Ahmed I, Thiessard F, Miremont-Salame G, Haramburu F, Kreft-Jais C, Begaud B, et al. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study. Drug Saf. 2012;35:495\u2013506.","journal-title":"Drug Saf."},{"key":"353_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/clpt.2013.24","volume":"93","author":"R Harpaz","year":"2013","unstructured":"Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther. 2013;93:539\u201346.","journal-title":"Clin Pharmacol Ther."},{"key":"353_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40264-013-0075-1","volume":"36","author":"J Slattery","year":"2013","unstructured":"Slattery J, Alvarez Y, Hidalgo A. Choosing thresholds for statistical signal detection with the proportional reporting ratio. Drug Saf. 2013;36:687\u201392.","journal-title":"Drug Saf."},{"key":"353_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40264-015-0289-5","volume":"38","author":"G Candore","year":"2015","unstructured":"Candore G, Juhlin K, Manlik K, Thakrar B, Quarcoo N, Seabroke S, Wisniewski A, Slattery J. Comparison of statistical signal detection methods within and across spontaneous reporting databases. Drug Saf. 2015;38:577\u201387.","journal-title":"Drug Saf."},{"key":"353_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pds.3454","volume":"23","author":"P Avillach","year":"2014","unstructured":"Avillach P, Salvo F, Thiessard F, Miremont-Salam\u00e9 G, Fourrier-Reglat A, Haramburu F, B\u00e9gaud B, Moore N, Pariente A, l\u2019Association des Centres R\u00e9gionaux de Pharmacovigilance. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases. Pharmacoepidemiol Drug Saf. 2014;23:186\u201394.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"353_CR20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00228-014-1658-1","volume":"70","author":"B Grundmark","year":"2014","unstructured":"Grundmark B, Holmberg L, Garmo H, Zethelius B. Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area. Eur J Clin Pharmacol. 2014;70:627\u201335.","journal-title":"Eur J Clin Pharmacol"},{"key":"353_CR21","first-page":"265","volume-title":"Data mining applications in engineering and medicine","author":"E Poluzzi","year":"2012","unstructured":"Poluzzi E, Raschi E, Piccinni C, De Ponti F. Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA Adverse Event Reporting System (AERS). In: Karahoca A, editor. Data mining applications in engineering and medicine. Croatia: Intech; 2012. p. 265\u2013302."},{"key":"353_CR22","first-page":"182","volume":"45","author":"M Huber","year":"2012","unstructured":"Huber M, Kolzsch M, Rapp MA, Wulff I, Kalinowski S, Bolbrinker J, Hofmann W, Scholze J, Dr\u00e4ger D, Kreutz R. Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia. Pharmacopsychiatry. 2012;45:182\u20138.","journal-title":"Pharmacopsychiatry."},{"key":"353_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jamda.2011.03.007","volume":"13","author":"T Richter","year":"2012","unstructured":"Richter T, Mann E, Meyer G, Haastert B, Kopke S. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med Dir Assoc. 2012;13:187.","journal-title":"J Am Med Dir Assoc."},{"key":"353_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/europace\/eut214","volume":"16","author":"G Sarganas","year":"2014","unstructured":"Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Europace. 2014;16:101\u20138.","journal-title":"Europace."},{"key":"353_CR25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jocn.2011.04.033","volume":"19","author":"M Huemer","year":"2012","unstructured":"Huemer M, Boldt LH, Wutzler A, Parwani A, Rolf S, Blaschke D, Haverkamp W. Polymorphic ventricular tachycardia in a patient with herpes encephalitis. J Clin Neurosci. 2012;19:483\u20134.","journal-title":"J Clin Neurosci."},{"key":"353_CR26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-199008000-00014","volume":"4","author":"AJ Cohen","year":"1990","unstructured":"Cohen AJ, Weiser B, Afzal Q, Fuhrer J. Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG). AIDS. 1990;4:807\u20139.","journal-title":"AIDS."},{"key":"353_CR27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00228-007-0366-5","volume":"63","author":"R Hulhoven","year":"2007","unstructured":"Hulhoven R, Rosillon D, Letiexhe M, Meeus MA, Daoust A, Stockis A. Levocetirizine does not prolong the QT\/QTc interval in healthy subjects: results from a thorough QT study. Eur J Clin Pharmacol. 2007;63:1011\u20137.","journal-title":"Eur J Clin Pharmacol."},{"key":"353_CR28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1365-2125.2012.04262.x","volume":"74","author":"C Caillet","year":"2012","unstructured":"Caillet C, Chauvelot-Moachon L, Montastruc JL, Bagheri H. Safety profile of enantiomers vs. racemic mixtures: it\u2019s the same? Br J Clin Pharmacol. 2012;74:886\u20139.","journal-title":"Br J Clin Pharmacol."},{"key":"353_CR29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00228-009-0695-7","volume":"65","author":"S Ravera","year":"2009","unstructured":"Ravera S, Hummel SA, Stolk P, Heerdink RE, de Jong-van den Berg LT, de Gier JJ. The use of driving impairing medicines: a European survey. Eur J Clin Pharmacol. 2009;65:1139\u201347.","journal-title":"Eur J Clin Pharmacol."},{"key":"353_CR30","unstructured":"Italian Regulatory Agency. Nota Informativa Importante su Tinset (oxatomide). http:\/\/www.agenziafarmaco.gov.it\/sites\/default\/files\/nii_final_cts_settembre_10_0.pdf . Accessed 21 Apr 2015."},{"key":"353_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9343(00)00564-7","volume":"109","author":"E Iglesias","year":"2000","unstructured":"Iglesias E, Esteban E, Zabala S, Gascon A. Tiapride-induced torsade de pointes. Am J Med. 2000;109:509.","journal-title":"Am J Med."},{"key":"353_CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4196\/kjpp.2010.14.5.305","volume":"14","author":"SH Jo","year":"2010","unstructured":"Jo SH, Lee SY. Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride. Korean J Physiol Pharmacol. 2010;14:305\u201310.","journal-title":"Korean J Physiol Pharmacol."},{"key":"353_CR33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hup.540","volume":"18","author":"SA Chong","year":"2003","unstructured":"Chong SA, Mythily, Lum A, Goh HY, Chan YH. Prolonged QTc intervals in medicated patients with schizophrenia. Hum Psychopharmacol. 2003;18:647\u20139.","journal-title":"Hum Psychopharmacol."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0353-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-015-0353-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0353-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:06:01Z","timestamp":1553612761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-015-0353-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s40264-015-0353-1","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}